The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
Carnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequen...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/22/6872 |
_version_ | 1797509172882833408 |
---|---|
author | Aman Upadhyay Kate E. Boyle Tom L. Broderick |
author_facet | Aman Upadhyay Kate E. Boyle Tom L. Broderick |
author_sort | Aman Upadhyay |
collection | DOAJ |
description | Carnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequences of type 1 diabetes, including hypoinsulinemia, hyperglycemia, and increased urine output. Systemic hypocarnitinemia, expressed as free carnitine levels, was evident in the plasma, liver, and kidney of diabetic rats. Compared to control rats, the low free carnitine in the plasma of diabetic rats was accompanied by decreased expression of γ-butyrobetaine hydroxylase in liver and kidney, suggesting impaired carnitine biosynthesis. Expression of organic cation transporter-2 in kidney was also reduced, indicating impaired renal reabsorption, and confirmed by the presence of elevated levels of free carnitine in the urine of diabetic rats. Insulin treatment of diabetic rats reversed the plasma hypocarnitinemia, increased the free carnitine content in both kidney and liver, and prevented urinary losses of free carnitine. This was associated with increased expression of γ-butyrobetaine hydroxylase and organic cation transporter-2. The results of our study indicate that type 1 diabetes induced with streptozotocin disrupts carnitine biosynthesis and renal uptake mechanisms, leading to carnitine insufficiency. These aberrations in carnitine homeostasis are prevented with daily insulin treatment. |
first_indexed | 2024-03-10T05:14:14Z |
format | Article |
id | doaj.art-aadbde9767c846b08b8b2a0e8cf5e801 |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-03-10T05:14:14Z |
publishDate | 2021-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-aadbde9767c846b08b8b2a0e8cf5e8012023-11-23T00:35:01ZengMDPI AGMolecules1420-30492021-11-012622687210.3390/molecules26226872The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal ExcretionAman Upadhyay0Kate E. Boyle1Tom L. Broderick2Department of Biomedical Sciences, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USAArizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ 85308, USALaboratory of Diabetes and Exercise Metabolism, Department of Physiology, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USACarnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequences of type 1 diabetes, including hypoinsulinemia, hyperglycemia, and increased urine output. Systemic hypocarnitinemia, expressed as free carnitine levels, was evident in the plasma, liver, and kidney of diabetic rats. Compared to control rats, the low free carnitine in the plasma of diabetic rats was accompanied by decreased expression of γ-butyrobetaine hydroxylase in liver and kidney, suggesting impaired carnitine biosynthesis. Expression of organic cation transporter-2 in kidney was also reduced, indicating impaired renal reabsorption, and confirmed by the presence of elevated levels of free carnitine in the urine of diabetic rats. Insulin treatment of diabetic rats reversed the plasma hypocarnitinemia, increased the free carnitine content in both kidney and liver, and prevented urinary losses of free carnitine. This was associated with increased expression of γ-butyrobetaine hydroxylase and organic cation transporter-2. The results of our study indicate that type 1 diabetes induced with streptozotocin disrupts carnitine biosynthesis and renal uptake mechanisms, leading to carnitine insufficiency. These aberrations in carnitine homeostasis are prevented with daily insulin treatment.https://www.mdpi.com/1420-3049/26/22/6872diabetescarnitinebiosynthesisuptakekidneyurine |
spellingShingle | Aman Upadhyay Kate E. Boyle Tom L. Broderick The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion Molecules diabetes carnitine biosynthesis uptake kidney urine |
title | The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion |
title_full | The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion |
title_fullStr | The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion |
title_full_unstemmed | The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion |
title_short | The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion |
title_sort | effects of streptozotocin induced diabetes and insulin treatment on carnitine biosynthesis and renal excretion |
topic | diabetes carnitine biosynthesis uptake kidney urine |
url | https://www.mdpi.com/1420-3049/26/22/6872 |
work_keys_str_mv | AT amanupadhyay theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion AT kateeboyle theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion AT tomlbroderick theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion AT amanupadhyay effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion AT kateeboyle effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion AT tomlbroderick effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion |